US2019269699A1PendingUtilityA1

Methods of treating epilepsy or status epilepticus

Assignee: SAGE THERAPEUTICS INCPriority: Aug 21, 2012Filed: May 22, 2019Published: Sep 5, 2019
Est. expiryAug 21, 2032(~6.1 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 25/08A61P 25/12A61P 25/10A61P 23/00A61K 31/573A61K 45/06A61K 31/57A61K 47/6951A61K 9/1605A61K 9/127A61K 9/1075A61K 9/107A61K 9/08A61K 9/0019A61K 47/40
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are methods of treating epilepsy or status epilepticus, e.g., convulsive status epilepticus, e.g., early status epilepticus, established status epilepticus, refractory status epilepticus, super-refractory status epilepticus, e.g., super-refractory generalized status epilepticus; non-convulsive status epilepticus, e.g., generalized status epilepticus, complex partial status epilepticus; generalized periodic epileptiform discharges; periodic lateralized epileptiform discharges; a seizure, e.g., acute repetitive seizures, cluster seizures, the method comprising administering to the subject a neuroactive steroid.

Claims

exact text as granted — not AI-modified
1 - 164 . (canceled) 
     
     
         165 . A method of preparing a formulation comprising allopregnanolone, said method comprising the step of high shear mixing an aqueous 5 mg/mL solution of allopregnanolone with 25% sulfo butyl ether beta-cyclodextrin solution. 
     
     
         166 . The method of  claim 165 , wherein the step of high shear mixing is performed for a period of time, characterized by a clear aqueous solution comprising 5 mg/mL allopregnanolone and 25% sulfo butyl ether beta-cyclodextrin. 
     
     
         167 . The method of  claim 166 , where the period of time is at least about 30 minutes.

Join the waitlist — get patent alerts

Track US2019269699A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.